Premium
Respiratory diseases caused by occupational exposure to 1,5‐naphthalene‐diisocyanate (NDI): Results of workplace‐related challenge tests and antibody analyses
Author(s) -
Baur X.,
Chen Z.,
Marczynski B.
Publication year - 2001
Publication title -
american journal of industrial medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 104
eISSN - 1097-0274
pISSN - 0271-3586
DOI - 10.1002/ajim.1027
Subject(s) - medicine , occupational asthma , immunoglobulin e , asthma , respiratory system , occupational exposure , allergy , antibody , bronchial hyperresponsiveness , occupational medicine , immunology , respiratory disease , environmental health , lung
Background 1,5‐naphthalene‐diisocyanate (NDI) is an aromatic diisocyanate with a very low vapor pressure which is mainly used in the automotive industry. Methods In the present study we described five cases with workplace‐related asthma and one case with extrinsic allergic alveolitis associated with pulmonary hemorrhage after NDI exposure. Results Corresponding to case histories, extrinsic alveolitis on asthmatic reactions in three subjects and a rhinitis reaction in one patient could be reproduced by inhalative challenge tests to NDI at a concentration of 10 ppb. Preliminary IgE and IgG antibody analyses in patients' sera did not produce significantly positive results. Conclusions According to the outcome of our tests and in comparison with several other studies, we conclude that NDI should be classified as potent airway‐sensitizing substance. Improved workplace conditions and decrease in threshold limit values should therefore be recommended. Am. J. Ind. Med. 39:369–372, 2001. © 2001 Wiley‐Liss, Inc.